{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T06:07:25Z","timestamp":1761977245910,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Canadian Journal of Cardiology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/j.cjca.2013.11.031","type":"journal-article","created":{"date-parts":[[2013,12,8]],"date-time":"2013-12-08T16:02:07Z","timestamp":1386518527000},"page":"237-243","source":"Crossref","is-referenced-by-count":2,"title":["Use and Misuse of Ezetimibe: Analysis of Use and Cost in Saskatchewan, a Canadian Jurisdiction With\u00a0Broad Access"],"prefix":"10.1016","volume":"30","author":[{"given":"Wasem M.","family":"Alsabbagh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Dagenais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinya","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Lix","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"Shevchuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary F.","family":"Teare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David F.","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cjca.2013.11.031_bib1","first-page":"44","article-title":"Ezetimibe's rapid US adoption called flawed","volume":"41","author":"Zoler","year":"2008","journal-title":"Int Med News"},{"key":"10.1016\/j.cjca.2013.11.031_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.7326\/0003-4819-151-9-200911030-00144","article-title":"Systematic review: comparative effectiveness and harms of combination therapy and monotherapy for dyslipidemia","volume":"151","author":"Sharma","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cjca.2013.11.031_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4065\/80.5.587","article-title":"A\u00a0community-based, randomized trial of ezetimibe added to statin therapy to attain NCEP ATP III goals for LDL cholesterol in hypercholesterolemic patients: the ezetimibe add-on to statin for effectiveness (EASE) trial","volume":"80","author":"Pearson","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.cjca.2013.11.031_bib4","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1016\/j.clinthera.2004.11.016","volume":"26","author":"Bays","year":"2004","journal-title":"Clin Ther"},{"key":"10.1016\/j.cjca.2013.11.031_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1185\/030079908X273273","article-title":"The efficacy of statin monotherapy uptitration versus switching to ezetimibe\/simvastatin: Results of the EASEGO study","volume":"24","author":"Roeters van Lennep","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.cjca.2013.11.031_bib6","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1161\/CIR.0b013e318235eb4d","article-title":"AHA\/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology foundation","volume":"124","author":"Smith","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.11.031_bib7","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s11883-010-0150-3","article-title":"What combination therapy with a statin, if any, would you recommend?","volume":"13","author":"Dujovne","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.cjca.2013.11.031_bib8","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1056\/NEJMsa0801461","article-title":"Use of ezetimibe in the United States and Canada","volume":"358","author":"Jackevicius","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cjca.2013.11.031_bib9","unstructured":"Government of Saskatchewan. Drug plan and extended benefits branch annual report 2010-2011. Available at: http:\/\/formulary.drugplan.health.gov.sk.ca\/Publns.aspx. Accessed December 23, 2013."},{"key":"10.1016\/j.cjca.2013.11.031_bib10","first-page":"228","article-title":"Changes in adherence to evidence-based medications in the first year after initial hospitalization for heart failure: observational cohort study from 1994 to 2003","volume":"2","author":"Lamb","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.cjca.2013.11.031_bib11","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4212\/cjhp.v62i1.113","article-title":"Evaluation of the accuracy of the Saskatchewan Health Pharmaceutical Information Program for determining a patient's medication use immediately before admission","volume":"62","author":"Tulloch","year":"2009","journal-title":"Can J Hosp Pharm"},{"key":"10.1016\/j.cjca.2013.11.031_bib12","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1159\/000015960","article-title":"Validity of stroke diagnosis on hospital discharge records in Saskatchewan, Canada: implications for stroke surveillance","volume":"9","author":"Liu","year":"1999","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.cjca.2013.11.031_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1592\/phco.2005.25.8.1035","article-title":"Cardiovascular morbidity associated with nonadherence to statin therapy","volume":"25","author":"Blackburn","year":"2005","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.cjca.2013.11.031_bib14","first-page":"485","article-title":"Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study","volume":"21","author":"Blackburn","year":"2005","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.11.031_bib15","doi-asserted-by":"crossref","first-page":"476","DOI":"10.18553\/jmcp.2009.15.6.476","article-title":"Retrospective observational assessment of statin adherence among subjects patronizing different types of community pharmacies in Canada","volume":"15","author":"Evans","year":"2009","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.cjca.2013.11.031_bib16","first-page":"853","article-title":"Approximations for standard errors of estimators of fixed and random effect in mixed linear models","volume":"79","author":"Kackar","year":"1984","journal-title":"J\u00a0Am Stat Assoc"},{"key":"10.1016\/j.cjca.2013.11.031_bib17","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2307\/2532317","article-title":"Generalized linear models with random effects; salamander mating revisited","volume":"48","author":"Karim","year":"1992","journal-title":"Biometrics"},{"key":"10.1016\/j.cjca.2013.11.031_bib18","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1093\/alcalc\/agp042","article-title":"The neighborhood alcohol environment and alcohol-related morbidity","volume":"44","author":"Theall","year":"2009","journal-title":"Alcohol Alcohol"},{"year":"1999","series-title":"Multilevel analysis: an introduction to basic and advanced multilevel modeling","author":"Snijders","key":"10.1016\/j.cjca.2013.11.031_bib19"},{"year":"1980","series-title":"Regression diagnostics: identifying influential data and sources of collinearity","author":"Belsley","key":"10.1016\/j.cjca.2013.11.031_bib20"},{"year":"1977","series-title":"Mathematical statistics: basic ideas and selected topics","author":"Bickel","key":"10.1016\/j.cjca.2013.11.031_bib21"},{"year":"2000","series-title":"Applied logistic regression","author":"Hosmer","key":"10.1016\/j.cjca.2013.11.031_bib22"},{"key":"10.1016\/j.cjca.2013.11.031_bib23","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0828-282X(06)70310-5","article-title":"Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement\u2014recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease","volume":"22","author":"McPherson","year":"2006","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.11.031_bib24","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.cjca.2013.11.031_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1177\/00912700122010915","article-title":"The plasma concentration and LDL-C relationship in patients receiving ezetimibe","volume":"41","author":"Ezzet","year":"2001","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.cjca.2013.11.031_bib26","doi-asserted-by":"crossref","DOI":"10.3310\/hta12210","article-title":"Ezetimibe for the treatment of hypercholesterolaemia: a systematic review and economic evaluation","volume":"12","author":"Ara","year":"2008","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.cjca.2013.11.031_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2012.05.007","volume":"223","author":"Perk","year":"2012","journal-title":"Atherosclerosis"},{"issue":"suppl 1","key":"10.1016\/j.cjca.2013.11.031_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP.18.S1.1","article-title":"American Association of Clinical Endocrinologists' guidelines for management of dyslipidemia and prevention of atherosclerosis","volume":"18","author":"Jellinger","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/j.cjca.2013.11.031_bib29","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0828-282X(09)70715-9","article-title":"2009 Canadian Cardiovascular Society\/Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult\u20142009 recommendations","volume":"25","author":"Genest","year":"2009","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.11.031_bib30","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11606-010-1253-9","article-title":"Primary medication non-adherence: analysis of 195,930 electronic prescriptions","volume":"25","author":"Fischer","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.cjca.2013.11.031_bib31","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.cjca.2011.05.007","article-title":"Diagnosis, prevention, and management of statin adverse effects and intolerance: Proceedings of a Canadian Working Group Consensus Conference","volume":"27","author":"Mancini","year":"2011","journal-title":"Can J Cardiol"},{"key":"10.1016\/j.cjca.2013.11.031_bib32","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1186\/1472-6963-12-290","article-title":"Evaluating the impact of a novel restricted reimbursement policy for quinolone antibiotics: a time series analysis","volume":"12","author":"Manns","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.cjca.2013.11.031_bib33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1258\/135581906775094253","article-title":"Impact of administrative restrictions on antibiotic use and expenditure in Ontario: time series analysis","volume":"11","author":"Marshall","year":"2006","journal-title":"J\u00a0Health Serv Res Policy"},{"key":"10.1016\/j.cjca.2013.11.031_bib34","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1093\/jac\/dkh501","article-title":"Effect of formulary policy decisions on antimicrobial drug utilization in British Columbia","volume":"55","author":"Marra","year":"2005","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.cjca.2013.11.031_bib35","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1345\/aph.1M620","article-title":"Assessment of changes in utilization of health-care services after implementation of a prior authorization policy for atypical antipsychotic agents","volume":"44","author":"Walthour","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.cjca.2013.11.031_bib36","first-page":"67","article-title":"The effect of a three-tier formulary on antidepressant utilization and expenditures","volume":"11","author":"Hodgkin","year":"2008","journal-title":"J\u00a0Ment Health Policy Econ"},{"key":"10.1016\/j.cjca.2013.11.031_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1586\/erp.10.87","article-title":"Combination of prescribing restrictions and policies to engineer low prices to reduce reimbursement costs","volume":"11","author":"Godman","year":"2011","journal-title":"Expert Rev Pharmacoecon Outcomes Res"}],"container-title":["Canadian Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13017133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0828282X13017133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T03:20:18Z","timestamp":1746069618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0828282X13017133"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S0828282X13017133"],"URL":"https:\/\/doi.org\/10.1016\/j.cjca.2013.11.031","relation":{},"ISSN":["0828-282X"],"issn-type":[{"type":"print","value":"0828-282X"}],"subject":[],"published":{"date-parts":[[2014,2]]}}}